I'll probably attend the following event (you can pre-register at www.biosf.org). If anyone else from SI will be attending, please PM me.
Marc
--------------------------------
BioScience Forum
Upcoming Meeting
Wednesday, November 16, 2005
The Checkered Past and Promising Future of Antibody Therapeutics
C. Geoff Davis, Ph.D.
Senior Vice President, Research
Abgenix
Abstract:
While antibodies have always been with us, the technology allowing us to isolate and produce antibodies with discreet specificities suitable for therapeutics was only developed as recently as the mid 1970s. From that time, another 20 years would pass before monoclonal antibodies would establish themselves as bona fide drugs. Today, there are 17 monoclonal antibodies approved and on the market, with over 150 more in clinical trials. This presentation will reexamine the technological breakthroughs that have elevated monoclonal antibodies to the forefront of biologics for treating a wide spectrum of human diseases.
Biography:
C. Geoffrey Davis, Ph.D. has served as Chief Scientific Officer since January 2000 and as Vice President, Research of Abgenix since June 1996. From January 1995 to June 1996, Dr. Davis was Director of Immunology at the Xenotech Division of Cell Genesys. From November 1991 to December 1994, he served at Repligen Corporation, a biotechnology company, first as Principal Investigator and then as Director of Immunology. Dr. Davis received a B.A. from Swarthmore College and a Ph.D. in immunology from the University of California, San Francisco.
Location:
Clarion Hotel
401 East Millbrae Avenue
Millbrae, California
Our web page (www.biosf.org) links to a map and directions to the Clarion Hotel |
